Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy
A Clinical Intervention Study Exploring Gastropexy as a Measure to Reduce Gastro-oesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy
Helse Forde
550 participants
Sep 4, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.
Eligibility
Inclusion Criteria1
- Patients planned for bariatric surgery with primary LSG
Exclusion Criteria4
- Age below 18 yrs
- Use of ARM for other reasons than reflux
- Previous antireflux surgery
- Inability to comprehend and respon to patient related outcome (PRO) questionnaire
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Gastropexy in this project means suturing the gastric remnant to the gastrocolic ligament.
Sleeve gastrectomy without suturing the gastric remnant to the gastrocolic ligament.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05704348